CoChat

miR-155 Drives Telomere Fragility in Human Breast Cancer by Targeting TRF1

Dinami, Roberto, Ercolani, Cristiana, Petti, Eleonora, Piazza, Silvano, Ciani, Yari, Sestito, Rosanna, Sacconi, Andrea, Biagioni, Francesca, le Sage, Carlos, Agami, Reuven, Benetti, Roberta, Mottolese, Marcella, Schneider, Claudio, Blandino, Giovanni, Schoeftner, Stefan · 2014 · Cancer Research
Cited by 126

The DOI matches its Crossref record; 11 of the 11 references it cites were found in a registry or an index.

Abstract

Telomeres consist of DNA tandem repeats that recruit the multiprotein complex shelterin to build a chromatin structure that protects chromosome ends. Although cancer formation is linked to alterations in telomere homeostasis, there is little understanding of how shelterin function is limited in cancer cells. Using a small-scale screening approach, we identified miR-155 as a key regulator in breast cancer cell expression of the shelterin component TERF1 (TRF1). miR-155 targeted a conserved sequence motif in the 3′UTR of TRF1, resulting in its translational repression. miR-155 was upregulated commonly in breast cancer specimens, as associated with reduced TRF1 protein expression, metastasis-free survival, and relapse-free survival in estrogen receptor–positive cases. Modulating miR-155 expression in cells altered TRF1 levels and TRF1 abundance at telomeres. Compromising TRF1 expression by elevating miR-155 increased telomere fragility and altered the structure of metaphase chromosomes. In contrast, reducing miR-155 levels improved telomere function and genomic stability. These results implied that miR-155 upregulation antagonizes telomere integrity in breast cancer cells, increasing genomic instability linked to poor clinical outcome in estrogen receptor–positive disease. Our work argued that miRNA-dependent regulation of shelterin function has a clinically significant impact on telomere function, suggesting the existence of “telo-miRNAs” that have an impact on cancer and aging. Cancer Res; 74(15); 4145–56. ©2014 AACR.

Overview

The claims and statistics of this paper haven’t been checked yet.

Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.

A few free checks a day · papers already verified open instantly · results are public

Integrity signals

Registry

Crossref · 10.1158/0008-5472.can-13-2038

Cites

11 of 11 references verified0 citation errors · 0 not checkable

Statistics

Verification

Claims the paper makes

The claims and statistics of this paper haven’t been checked yet.

Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.

A few free checks a day · papers already verified open instantly · results are public

Self-check

Percentages, sums and reported differences re-computed from the paper’s own numbers.

The self-check needs the paper’s full text.

Citations

Cites

Show all 11 references

Cited by

See all 126

Metadata

Authors
Dinami, R., Ercolani, C., Petti, E., Piazza, S., Ciani, Y., Sestito, R., Sacconi, A., Biagioni, F., le Sage, C., Agami, R., Benetti, R., Mottolese, M., Schneider, C., Blandino, G., & Schoeftner, S.
Venue
Cancer Research
Published
2014-07-31
Volume
74
Issue
15
Pages
4145-4156
ISSN
  • 0008-5472 (ISSN-L)
  • 1538-7445
OpenAlex
W2053028783
Cited by
126
References
11
FWCI
10.50
Type
journal article
Language
en
Open access
closed

About these checks

Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.

Statistics and arithmetic are recomputed, not judged.

Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.

What counts as a claim ›How we measure confidence ›How we check this ›

Are you an author, or do you see a problem with this page? Request a review

How to cite

Cite CoChat for the checks on this page, and the paper for its own findings.

This page
CoChat. (2026). Citation check: miR-155 Drives Telomere Fragility in Human Breast Cancer by Targeting TRF1. https://app.cochat.ai/papers/10.1158/0008-5472.can-13-2038
The paper
Dinami, R., Ercolani, C., Petti, E., Piazza, S., Ciani, Y., Sestito, R., Sacconi, A., Biagioni, F., le Sage, C., Agami, R., Benetti, R., Mottolese, M., Schneider, C., Blandino, G., & Schoeftner, S. (2014). miR-155 Drives Telomere Fragility in Human Breast Cancer by Targeting TRF1. Cancer Research. https://doi.org/10.1158/0008-5472.can-13-2038

Data sources

Bibliographic data: Semantic Scholar, OpenAlex, Crossref.

Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).

Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.